Demars Financial Group LLC Purchases 52 Shares of Humana Inc. (NYSE:HUM)

Demars Financial Group LLC increased its stake in shares of Humana Inc. (NYSE:HUM) by 2.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,950 shares of the insurance provider’s stock after purchasing an additional 52 shares during the quarter. Demars Financial Group LLC’s holdings in Humana were worth $618,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Creative Financial Designs Inc. ADV increased its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. lifted its stake in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Atwood & Palmer Inc. acquired a new stake in shares of Humana during the 3rd quarter worth about $29,000. Your Advocates Ltd. LLP raised its stake in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares in the last quarter. Finally, Hantz Financial Services Inc. acquired a new stake in Humana in the 2nd quarter worth about $35,000. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on HUM shares. Truist Financial dropped their target price on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research report on Friday, October 11th. Wells Fargo & Company reduced their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 target price on shares of Humana in a research note on Tuesday, October 1st. Leerink Partnrs lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, UBS Group decreased their price objective on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Stock Up 0.1 %

NYSE HUM traded up $0.36 during trading hours on Friday, hitting $288.12. 1,691,681 shares of the company were exchanged, compared to its average volume of 2,587,340. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The firm has a market cap of $34.69 billion, a price-to-earnings ratio of 25.53, a PEG ratio of 2.28 and a beta of 0.52. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a 50 day moving average of $289.38 and a two-hundred day moving average of $332.67.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Equities research analysts anticipate that Humana Inc. will post 15.83 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.